Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 8/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | USP14 | P54578 | 1/20 | 0.31 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.31 |
| ▸ | IGF1R | P08069 | 1/20 | 0.31 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.31 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.31 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12721865 | 0.99 | FFAR1 (0.34) | FFAR1SCN9ARENJAK2JAK3 | |
| SCHEMBL12721750 | 0.98 | JAK2 (0.35) | FFAR1SCN9ARENJAK2JAK3 | |
| SCHEMBL12722039 | 0.97 | REN (0.36) | FFAR1SCN9ARENJAK2JAK3 | |
| SCHEMBL12722002 | 0.96 | REN (0.36) | FFAR1SCN9ARENJAK2JAK3 | |
| SCHEMBL12721953 | 0.96 | NR3C1 (0.35) | FFAR1SCN9ARENNR3C1DHODH | |
| SCHEMBL12722021 | 0.96 | REN (0.36) | FFAR1SCN9ARENJAK2JAK3 | |
| SCHEMBL12721951 | 0.95 | SCN9A (0.33) | FFAR1SCN9ARENJAK2JAK3 | |
| SCHEMBL12721928 | 0.92 | FFAR1 (0.31) | FFAR1SCN9AREN | |
| SCHEMBL13249695 | 0.92 | NTRK1 (0.34) | MAPTTP53ALDH1A1USP14NTRK1 | |
| SCHEMBL13249705 | 0.92 | JAK2 (0.35) | JAK2JAK3NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7754349-B2 | Silanylamine-based compound and organic light-emitting device including organic layer including the silanylamine-based compound | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2010-07-13 | — | — | US | disclosed |
| US-20080171227-A1 | SILANYLAMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE SILANYLAMINE-BASED COMPOUND | SAMSUNG SDI CO., LTD. (KR) | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171227-A1 | SILANYLAMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC LAYER INCLUDING THE SILANYLAMINE-BASED COMPOUND | ADRB2, ADRB1, ADRB3 | FFAR1 2841/4885SCN9A 230/4885REN 2977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.